Quest Diagnostics SVP Executes $588,729 Stock Sale; Holdings Remain Intact After Award Settlement
Patrick Plewman, senior vice president for Diagnostic Services at Quest Diagnostics (DGX), completed a planned sale of 2,855 shares on March 5, 2026, for $588,729 under a Rule 10b5-1 plan. The transactions followed the settlement of a performance stock award and occurred as the stock traded near its 52-week high. Plewman’s direct ownership after th…